Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer
Completed · Phase 1
Conditions studied: Lung Cancer
In brief
Phase I trial to study the effectiveness of radiation therapy plus topotecan in treating patients who have non-small cell lung cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy and radiation therapy may kill more tumor cells.
Key facts
- Study ID
- NCT00002537
- Run by
- National Cancer Institute (NCI)
- People needed
- 20
- Starts
- 1993-09-01
- Last updated by the study team
- 2013-02-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- NYU School of Medicine's Kaplan Comprehensive Cancer Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.